Types of Fixation of Vancouver B1 Periprosthetic Fractures

Overview

The purpose of this study is to compare two different but standard treatments for the fixation of Vancouver B1 periprosthetic. The investigators aim to compare open reduction internal fixation using a locked plating system versus plating and strut allograft with cerclage wiring to determine which treatment results in a faster return to function as measured by the TUG test at 6 weeks post-op.

Full Title of Study: “Isolated Locked Compression Plating Versus Cable Plating and Strut Allografts With Cerclage Wiring for Vancouver B1 Periprosthetic Femoral Fractures: A Randomized Controlled Trial”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: None (Open Label)
  • Study Primary Completion Date: June 2023

Interventions

  • Procedure: Isolated Locked Compression Plate
    • A lateral thigh incision will be used to expose the fracture site. Surgeons will attempt to minimize devascularization of the bone by meticulous dissection and indirect reduction techniques. An appropriate sized plate will be applied to the lateral aspect of the femur. Fracture reduction will be achieved with the use of intra-operative fluoroscopy and the plate will be secured with locking screws.
  • Procedure: Cable Plating and Strut Allograft with Cerclage Wiring
    • The plate will be placed laterally with the allograft strut placed on the anterior cortex. Screw fixation will be used distal to the stem and cables and screws will be used proximal to the stem tip. Cerclage cables or wires will be used to secure the strut.

Arms, Groups and Cohorts

  • Active Comparator: Cable plating with strut
    • The plate will be placed laterally with the allograft strut placed on the anterior cortex. Screw fixation will be used distal to the stem and cables and screws will be used proximal to the stem tip. Cerclage cables or wires will be used to secure the strut.
  • Active Comparator: isolated plating
    • A lateral thigh incision will be used to expose the fracture site. Surgeons will attempt to minimize devascularization of the bone by meticulous dissection and indirect reduction techniques. An appropriate sized plate will be applied to the lateral aspect of the femur. Fracture reduction will be achieved with the use of intra-operative fluoroscopy and the plate will be secured with locking screws.

Clinical Trial Outcome Measures

Primary Measures

  • TUG test score at 6 weeks post-op
    • Time Frame: 6 weeks
    • We will administer the TUG test to each patient at 6 weeks to determine if there is a difference in functional status between both groups.

Secondary Measures

  • Re-operation rates
    • Time Frame: 1 year
    • We will measure rates of re-operationin each of the treatment groups on study specific case report forms.

Participating in This Clinical Trial

Inclusion Criteria

  • Age: over 18, no upper limit – Vancouver type B1 periprosthetic fracture – Fracture is amenable to either treatment group – Prosthesis is well fixed – Provision of informed consent Exclusion Criteria:

  • Presence of an active infection around the fracture (soft tissue or bone) – Loose prosthesis – Trauma patients with an ISS > 16 or associated major injuries of the lower extremities – Known substance abuse – Likely problems, in the judgment of the investigators, with maintaining follow-up (i.e., patients with no fixed address, report a plan to move out of town, or intellectually challenged patients without adequate family support)

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: 90 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Unity Health Toronto
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Emil Schemitsch, MD, FRCS(C), Principal Investigator, Unity Health Toronto
    • Aaron Nauth, MD, FRCSC, Principal Investigator, Unity Health Toronto
  • Overall Contact(s)
    • Emil Schemitsch, MD, FRCS(C), 416-864-6003, schemitsche@smh.ca

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.